Patients With Intransit Stage III/IV Melanoma
1 clinical trials · Condition
◉ Watch Patients With Intransit Stage III/IV Melanoma
| Record | Firm | Date |
|---|---|---|
| Phase 1 Dose-finding Study of L19TNFα Plus Melphalan Using Isolated Inferior Limb Perfusion (ILP) in Subjects With Intransit Stage III/IV Melanoma (NCT01213732) | Philogen S.p.A. | 2008-10-01 |
Track Patients With Intransit Stage III/IV Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.